Budesonide in the treatment of refractory celiac disease

American Journal of Gastroenterology

Volumn 102, Issue 10, 2007, Pages 2265-2269

  Brar, Pardeep ^a   Lee, Susie ^a   Lewis, Suzanne ^a   Egbuna, Ikenna ^a   Bhagat, Govind ^a   Green, Peter H R ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Harkness Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; PREDNISONE; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DEFECATION HABIT; DIET THERAPY; DRUG DOSE REDUCTION; DUODENUM BIOPSY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE MOTILITY; INTESTINE VILLUS ATROPHY; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MICROSCOPIC COLITIS; PATIENT CODING; PRIORITY JOURNAL; REFRACTORY PERIOD; SUSTAINED DRUG RELEASE; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AZATHIOPRINE; BUDESONIDE; CELIAC DISEASE; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34848889667     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01380.x     Document Type: Article

References (30)

1. Green PH, Jabri B. Coeliac disease. Lancet 2003 362 : 383 91.
2. Pink IJ, Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1967 1 : 300 4.
3. O'Mahony S, Howdle PD, Losowsky MS. Review article: Management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996 10 : 671 80.
4. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000 119 : 243 51.
5. Abdulkarim AS, Burgart LJ, See J, et al. Etiology of nonresponsive celiac disease: Results of a systematic approach. Am J Gastroenterol 2002 97 : 2016 21.
6. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005 19 : 413 24.
7. Hamilton JD, Chambers RA, Wynn-Williams A. Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet 1976 1 : 1213 6.
8. Trier JS. Celiac sprue. N Engl J Med 1991 325 : 1709 19.
9. Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003 18 : 487 94.
10. Ciclitira PJ, King AL, Fraser JS. AGA technical review on celiac sprue. American Gastroenterological Association. Gastroenterology 2001 120 : 1526 40.
11. Edsbacker S, Larsson P, Wollmer P. Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules. Eur J Gastroenterol Hepatol 2002 14 : 1357 62.
12. Edsbacker S, Bengtsson B, Larsson P, et al. A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules. Aliment Pharmacol Ther 2003 17 : 525 36.
13. Bottaro M, Berti E, Biondi A, et al. Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 1994 83 : 3271 8.
14. Maurino E, Niveloni S, Chernavsky A, et al. Azathioprine in refractory sprue: Results from a prospective, open-label study. Am J Gastroenterol 2002 97 : 2595 602.
15. Rolny P, Sigurjonsdottir HA, Remotti H, et al. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999 94 : 219 25.
16. Vaidya A, Bolanos J, Berkelhammer C. Azathioprine in refractory sprue. Am J Gastroenterol 1999 94 : 1967 9.
17. Longstreth GF. Successful treatment of refractory sprue with cyclosporine. Ann Intern Med 1993 119 : 1014 6.
18. Gillett HR, Arnott ID, McIntyre M, et al. Successful infliximab treatment for steroid-refractory celiac disease: A case report. Gastroenterology 2002 122 : 800 5.
19. Turner SM, Moorghen M, Probert CS. Refractory coeliac disease: Remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 2005 17 : 667 9.
20. Macdonald WC, Brandborg LL, Flick AL, et al. Studies of celiac sprue IV. The response of the whole length of the small bowel to a gluten-free diet. Gastroenterology 1964 47 : 573 89.
21. Dickey W, Hughes DF. Histology of the terminal ileum in coeliac disease. Scand J Gastroenterol 2004 39 : 665 7.
22. Culliford A, Daly J, Diamond B, et al. The value of wireless capsule endoscopy in patients with complicated celiac disease. Gastrointest Endosc 2005 62 : 55 61.
23. Bramble MG, Watson AJ, Scott J, et al. Clinical, biochemical and morphological responses of patients with villous atrophy to oral betamethasone valerate and clobetasone butyrate. Digestion 1981 22 : 281 8.
24. Mitchison HC, al Mardini H, Gillespie S, et al. A pilot study of fluticasone propionate in untreated coeliac disease. Gut 1991 32 : 260 5.
25. Chopra A, Pardi DS, Loftus EV, et al. Budesonide in the treatment of inflammatory bowel disease: The first year of experience in clinical practice. Inflamm Bowel Dis 2006 12 : 29 32.
26. Daum S, Ipczynski R, Heine B, et al. Therapy with budesonide in patients with refractory sprue. Digestion 2006 73 : 60 8.
27. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000 356 : 203 8.
28. Greco L, Corazza G, Babron MC, et al. Genome search in celiac disease. Am J Hum Genet 1998 62 : 669 75.
29. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000 95 : 712 4.
30. Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: A retrospective clinical study of 199 Swedish patients. Gut 2004 53 : 536 41.